Overview
Cevimeline is a synthetic cholinergic agonist that binds to muscarinic receptors, particularly M1 and M3 subtypes. It was developed as a successor to pilocarpine for treating xerostomia (dry mouth) associated with Sjögren's syndrome, an autoimmune disorder affecting exocrine glands. The drug received FDA approval in 2000 and is marketed under the brand name Evoxac. As a quinuclidine derivative, cevimeline exhibits higher receptor specificity than older cholinergic drugs, reducing side effects while maintaining efficacy. Its primary mechanism involves stimulating salivary and sweat gland secretion through parasympathetic nervous system activation.
Physical and Chemical Properties
Cevimeline hydrochloride is the commonly used salt form, appearing as a white crystalline powder with good solubility in water (≥50 mg/mL) and ethanol. The compound shows stability under recommended storage conditions but may degrade upon prolonged exposure to light or humidity. The molecular structure features a thiolane ring connected to a quinuclidine moiety, contributing to its receptor-binding affinity. Its pKa values (8.1 for the tertiary amine) influence absorption characteristics, with optimal bioavailability occurring in slightly acidic environments. Thermal analysis reveals decomposition above 200°C.
Main Applications
The primary clinical use of cevimeline is managing sicca symptoms in Sjögren's syndrome patients, improving salivary flow rates by 50-100% in clinical trials. Off-label applications include radiation-induced xerostomia and dry mouth from antidepressant medications. In pharmaceutical manufacturing, cevimeline serves as an active pharmaceutical ingredient (API) for capsule formulations, typically in 30 mg doses. Recent research explores its potential in neurodegenerative disorders due to CNS penetration, though this remains investigational. Industrial-scale synthesis involves multi-step organic reactions with strict purity controls.
Safety and Storage
Cevimeline requires careful handling as a Schedule IV controlled substance in some jurisdictions. Workplace exposure limits follow general API guidelines (≤1 mg/m³ for respirable dust). Personal protective equipment including gloves and N95 masks is recommended during bulk processing. Storage must maintain product integrity: sealed containers under nitrogen atmosphere at 2-8°C protect against oxidation. Shelf life typically reaches 36 months when properly stored. Stability indicators include color change (yellowing suggests degradation) and HPLC purity tests. Emergency procedures for spills involve neutralization with dilute acid and absorption with inert material.
B2B Procurement Guide
Pharmaceutical purchasers should prioritize suppliers with: 1. Current Good Manufacturing Practice (cGMP) certification 2. ISO 9001:2015 quality systems 3. Batch-specific Certificate of Analysis (CoA) showing ≥99% purity Order lead times average 4-8 weeks for custom synthesis. Minimum order quantities (MOQs) often start at 1 kg for API-grade material, with bulk discounts available above 10 kg. Key negotiation points include validated analytical methods, impurity profiles, and regulatory support documentation (DMF/ASMF). For clinical trial supplies, ensure the vendor can provide appropriate stability data (ICH Q1A guidelines) and endotoxin testing (<0.5 EU/mg). Cold chain logistics are mandatory for international shipments.
Related Manufacturers
- 主营：对照品、科研实验、试剂盒、多糖、安石榴苷、儿茶素、绿原酸、尿石素、人参皂苷、花青素、维生素、异鼠李素、甘草系列、人参系列、补骨脂系列、雷公藤系列、黄芩系列、柴胡系列、丹参系列、酸枣仁系列、重楼系列、大黄系列、五味子系列、化合物、黄芪皂苷系列
- 主营：二乙基、黄棕6gd、异戊酯、盐酸西维美林半水合物、草酸镍、草酸镱、香叶酯、赤松素、硫化钇、硫酸锂、锡酸钠、氯苯基、甲硫基、硫化黑、精氨酸、cnidimola、甘氨酰、平平加、溴喹啉、地衣酸、松脂素、锑酸钠、氟苯肼、硼酸盐、氯吡唑、硼酸锌
- 主营：甘氨酰、clausined、酸性橙、硫酸锑、基嘧啶、氟甲烷、硫酸锂、二氰基、硫酸锰、dl-半胱、氰基苯、peraksine、含苯基、磷酸银、丁酸铝、锑酸钠、中性红、碳酸镉、磷酸铝、茵芋碱、海松酸、乙醇铁、叶绿素、氟苯基、碲化钠